Mechanisms of Disease: detrimental adrenergic signaling in acute decompensated heart failure
Open Access
- 19 February 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Cardiovascular Medicine
- Vol. 5 (4), 208-218
- https://doi.org/10.1038/ncpcardio1127
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Management Strategies for Stage‐D Patients with Acute Heart FailureClinical Cardiology, 2007
- Targeting of phospholamban by peroxynitrite decreases β-adrenergic stimulation in cardiomyocytesCardiovascular Research, 2007
- Chronic cardiac resynchronization therapy and reverse ventricular remodeling in a model of nonischemic cardiomyopathyLife Sciences, 2007
- β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotectionJCI Insight, 2007
- Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channelsJCI Insight, 2006
- β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytesProceedings of the National Academy of Sciences of the United States of America, 2006
- Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosisProceedings of the National Academy of Sciences of the United States of America, 2006
- Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failureNature Clinical Practice Cardiovascular Medicine, 2005
- Hydroxyl Radical-Induced Acute Diastolic Dysfunction Is Due to Calcium Overload via Reverse-Mode Na + -Ca 2+ ExchangeCirculation Research, 2002
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureThe New England Journal of Medicine, 1996